Abiopharma

🔍 Kucinski Thomas S. (Executive)

Company: Information Services Group Inc. (III)

Report Date: 2026-08-18

Detailed Transactions and Holdings:

• Acquired 7,764 shares of Shares of Common Stock (Direct)
  Date: 2026-08-18 | Code: M | equity_swap_involved: 0 | shares_owned_after: 340,781.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 4,197 shares of Shares of Common Stock at $4.93 per share (Direct)
  Date: 2026-08-18 | Code: F | equity_swap_involved: 0 | shares_owned_after: 336,820.00 | transaction_form_type: 4 | Footnotes: F2, F3
• Sold 7,764 shares of Performance Based RSUs (Derivative)
  Date: 2026-08-18 | Code: M | Expires: 2029-06-02 | Exercise: 2026-08-18 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1

Footnotes:

• F1: On June 2, 2025, the Reporting Person received a grant of RSUs that could be earned based on the achievement of market price goals, which were measured as the average closing price of issuer's common stock over any ten consecutive trading day period beginning with the first anniversary of the award. 100% of the number of RSUs will be earned if the measured market price is $5.00 or above This performance condition was met on August 18, 2026, and 100% of the performance-based RSUs were fully vested.
• F2: Represents deemed disposition of shares of common stock to the Issuer as a result of withholding of shares of common stock to satisfy tax withholding obligations in connection with vesting of restricted stock units issued in accordance with Rule 16b-3.
• F3: Includes 236 shares acquired under the Information Services Group, Inc. Amended and Restated 2007 Employee Stock Purchase Plan.